# Italfarmaco

Source: https://onco.cc/companies/italfarmaco/  
OnCo record `italfarmaco` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Italfarmaco is a Italy-based pharmaceutical company running 2 late-stage cancer trials of givinostat and Givinostat in myeloproliferative neoplasms.

## Summary

Italfarmaco, based in Milan, Italy, is a pharmaceutical company. Italfarmaco is a pharmaceutical group that researches, develops and manufactures medicines, with a particular focus on rare diseases. On ClinicalTrials.gov it is the lead sponsor of 2 recruiting or active phase 2 and phase 3 interventional cancer trials (1 in phase 3), testing givinostat and Givinostat in myeloproliferative neoplasms. The largest, NCT06093672 (Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera), plans to enrol 220 participants. Sponsor and trial facts are from the ClinicalTrials.gov registry; company facts are from the official website.

## Fields

- Kind: Company
- Last checked: 2026-09-11
- Tags: ctgov-sponsor
- HQ: Milan
- Type: pharma
- Website: https://www.italfarmaco.com

## Sources

- Official website: https://www.italfarmaco.com
- ClinicalTrials.gov: trials led by Italfarmaco: https://clinicaltrials.gov/search?lead=Italfarmaco

## Connected records

- cancers: [Myeloproliferative neoplasms (PV, ET, myelofibrosis)](https://onco.cc/cancers/myeloproliferative-neoplasms/)
- drugs: [Givinostat](https://onco.cc/drugs/givinostat/)
- trials: [Long-term Study Evaluating the Effect of Givinostat in Patients With Chronic Myeloproliferative Neoplasms](https://onco.cc/trials/nct01761968/), [Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera](https://onco.cc/trials/nct06093672/)

---
JSON: https://onco.cc/api/v1/entities/italfarmaco.json